[Idiopathic generalized epilepsies with absence seizures with valproic acid treatment: neuropsychological disorders]

P A Conde-Guzon1, R Cancho-Candela

  • 1Área de Personalidad, Evaluación y Tratamiento Psicológicos, Campus de Vegazana, Universidad de León, E-24071 León. pacong@unileon.es

Insights

Children with absence seizures treated with valproate show significant deficits in memory and attention. Neuropsychological assessments reveal lower verbal IQ and specific impairments in logical, short-term auditory, and visual memory.

Area of Science:

  • Neuropsychology
  • Pediatric Neurology
  • Epileptology

Context:

  • Absence seizures are a common epilepsy syndrome in children.
  • Valproate is a frequently prescribed antiepileptic drug for this condition.
  • Understanding the cognitive impact of absence seizures and their treatment is crucial for effective management.

Purpose:

  • To analyze the neuropsychological profile of children diagnosed with absence seizures and treated with valproate.
  • To compare the cognitive functions of these children with a healthy control group.
  • To identify specific areas of neuropsychological deficit.

Summary:

  • Children with absence seizures on valproate exhibited significantly lower verbal IQ than controls, though still within the normal range.
  • Neuropsychological testing using the Luria-DNI Battery revealed significant deficits across multiple domains, including memory, reading, writing, and articulation.
  • A notable memory deficit was observed, particularly in short-term auditory and visual memory, and logical memory, despite preserved shape memory.
  • Attentional profiles were also generally deteriorated in the epileptic group compared to controls.

Impact:

  • The findings highlight the need for systematic neuropsychological and cognitive assessments in children with absence seizures at diagnosis and during follow-up.
  • This research can inform the development of targeted psychoeducational interventions to support children with epilepsy.
  • Early identification of cognitive difficulties can lead to better academic and developmental outcomes for affected children.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...